INLIF Ltd (INLF) Stock Analysis
Verdict: AVOID
Repeated reverse splits and a proposed 8.5B share expansion pose catastrophic dilution risk despite short-term EGM speculative pumps.
Investment score: 18/100
Analysis as of
Is INLIF Ltd stock worth reviewing? AI model thesis
The model rates INLIF Ltd an AVOID due to severe dilution risk from an approved proposal expanding authorized shares to 8.5 billion, consecutive reverse splits (1-for-16 and 1-for-200 in 2026), and a net loss of $5.45M in 2025.
7-factor investment score
- Valuation: 30/100 (weight 20%)
- Financial Health: 25/100 (weight 15%)
- Technical Momentum: 20/100 (weight 15%)
- Earnings Quality: 10/100 (weight 15%)
- Insider Sentiment: 15/100 (weight 10%)
- Analyst Consensus: 10/100 (weight 10%)
- Risk-Adjusted Return: 10/100 (weight 15%)
INLIF Ltd opportunities and risks
What speaks for INLF
- Expansion into battery cell packing machines secured a $4.4M commercial order in June 2026
What speaks against INLF
- EGM approval expanding authorized ordinary share capital from 1.09M to 8.5 billion shares
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| INLF | 0.7x | 0.0x | 16.7x | 32.8% | -11.7% | -62675.4% |
| ZJK | 13.8x | 2.1x | 7.7x | 40.6% | 14.7% | 2.7% |
| VALV | 0.0x | 0.0x | n/a | 43.2% | 7.5% | 129318.4% |
| Peer median | 6.9x | 1.0x | n/a | 41.9% | 11.1% | 64660.6% |
Frequently asked questions about INLIF Ltd (INLF)
Is INLF stock a good investment?
The cached TradeMates AI model rates INLIF Ltd as AVOID with an investment score of 18/100. The model rates INLIF Ltd an AVOID due to severe dilution risk from an approved proposal expanding authorized shares to 8.5 billion, consecutive reverse splits (1-for-16 and 1-for-200 in 2026), and a net loss of $5.45M in 2025. This is algorithmic model output, not personal investment advice.
Is INLF stock a buy?
The TradeMates model verdict for INLF is AVOID with an investment score of 18/100. Treat this as a model signal to review, not a personal buy recommendation.